The brain that wasn’t supposed to heal The Atlantic
Steve Mishkin’s unexpected recovery is a case study in luck, split-second decisions, and the many, many things that need to go right for a trauma patient to get well.
The lost girls Spectrum
Misdiagnosed, misunderstood or missed altogether, many women with autism struggle to get the help they need.
How shock therapy is saving some children with autism Spectrum
Given its reputation, the most shocking thing about electroconvulsive therapy might be how beneficial — and banal — it actually is.
Man-eater overload The New Yorker
Tiger attacks on the thousands of tribal people who live on Indian park lands have been escalating.
Appropriate technology: Make anything, anywhere Nature
Can everyone use technology creatively? Engineers at the Massachusetts Institute of Technology think so and have launched ‘Fab Labs’ around the world to prove it.
DDT returns Nature Medicine
The most infamous pesticide in history is also the most effective weapon against malaria. Ready or not, DDT is on its way back to Africa.
Visual neuroscience: Look and learn Nature
Prevailing wisdom says the adult brain cannot learn to see if it had no visual stimulation during childhood, but blind people in India seem to be breaking all the rules.
India’s government is becoming increasingly anti-science Scientific American
Scientists join writers, artists and historians in protesting the Modi government’s growing interference in academic affairs.
Alone in a room full of science writers LadyBits on Medium
On being the only Indian woman at a science writers’ conference.
What’s in a name? Whatever you’d like Spectrum
What does ‘autism’ mean? And who owns this term? A keynote talk at the 2015 International Meeting for Autism Research dove headlong into this rabbit hole of words and their many meanings.
Held to ransom Nature
A pharma giant’s decision to withhold new drugs from Thailand will only hurt patients, says Apoorva Mandavilli.
Big issues from a small child Nature
How far can a parent go in managing the life of their disabled child? Perhaps too far.
Female scientists turn to data to fight lack of representation on panels The New York Times
Noticing the skewed lineups at conferences, a Princeton neuroscientist and colleagues have started a website to compare the gender ratios at conferences.
One Year after Sandy, Uneven Recovery at New York University’s labs Scientific American
Walking through Gordon Fishell’s lab now, you would never know that much of his research was swept away by last year’s superstorm. Other scientists at New York University’s medical center cannot say the same.
Large study quantifies risk of autism in ‘baby sibs’ Spectrum
One in every five younger siblings of children with autism will end up being diagnosed with the disorder, according to the largest analysis to date of these ‘baby sibs.’
Superfast TB test slashes waiting time Nature
Infection with tuberculosis can be diagnosed easily and accurately in less than two hours.
Genetic variant predicts heart disease risk Technology Review
A newly identified risk factor for heart disease also seems to indicate which patients will benefit from popular statin therapies.
Scientists, NIH in conflict over precious HIV samples Nature Medicine
The NIH won’t fund projects on acute HIV infection, researchers say.
Indian bioscience: The anti-bureaucrat Nature
K. VijayRaghavan is determined to cut through red tape and build up biological science in India.
India’s watchdog: A breath of fresh air Nature, February 2007
How often does independent research change laws as well as minds? A lobby group in Delhi is forcing the Indian government into new regulations. Apoorva Mandavilli meets its leader.
Stephen Lewis Nature Medicine, October 2006
In a roomful of stuffy diplomats, Stephen Lewis stands out for his powerful rhetoric and punchy humor. More than once, his habit for speaking uncomfortable truths has shamed governments into action.
Thomas Frieden Nature Medicine, April 2006
It’s not often that the health official of a city makes global headlines—even when the city in question is New York. With his daring policies on HIV, diabetes and smoking, Thomas Frieden is putting New York on the map.
Dominique Toran-Allerand Nature Medicine, October 2005
Don’t call her a women’s health researcher, but Dominique Toran-Allerand knows more about estrogen than almost anyone else. And she earned that knowledge by questioning dogma every step of the way.
Woo-Suk Hwang Nature Medicine, May 2005
In the West, Woo-Suk Hwang is an enigma. In his home country, he is a scientist with perhaps too much power. In either place, he is a stem cell star.
David Ho Nature Medicine, November 2004
Credited with some of the biggest breakthroughs in tackling HIV/AIDS, David Ho has been a star from the beginning. But in a field fraught with controversy, fame may have come at a cost.
Yusuke Nakamura Nature Medicine, June 2004
Yusuke Nakamura might not win any popularity contests in his homeland, but friends and rivals agree that his unique blend of scientific skill and financial savvy makes him the most influential force in Japanese research.
Marc Tessier-Lavigne Nature Medicine, January 2004
How do you top solving a century-old riddle in developmental neurobiology? By moving to a company with no commercial interest in neuroscience. For someone as ambitious as Marc Tessier-Lavigne, leaving academia for the biotech giant Genentech could be the perfect choice.